Retention in Care among People Living with Chronic Hepatitis B Virus Infection in Burkina Faso: A 17-Year Retrospective Cohort Study
- 1 Service d’Hépato-gastroentérologie du CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso
- 2 Service d’Hépato-gastroentérologie du CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso
- 3 Service d’Hépato-gastroentérologie du CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso
- 4 Service d’Hépato-gastroentérologie du CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso
- 5 Service d’Hépato-gastroentérologie du CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso
- 6 Service d’Hépato-gastroentérologie du CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso
- 7 Service d’Hépato-gastroentérologie du CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso
- 8 Service d’Hépato-gastroentérologie du CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso
- 9 Service d’Hépato-gastroentérologie du CHR de Fada N’Gourma, Fada N’Gourma, Burkina Faso
- 10 UFR/SDS Université Joseph KI-ZERBO, Ouagadougou, Burkina Faso
Abstract
Background/ Aim : Retention in care remains a major challenge in the care programs for people with chronic Hepatitis B virus (PL-HBV). This study aimed to evaluate non-retention in care and identify its associated factors among PL-HBV in the HEPSANET cohort at the Yalgado Ouédraogo University Hospital. Patients and Method: This was a retrospective, analytical cohort study conducted over 17 years (January 2006-January 2023). People living with the hepatitis B virus who were at least 18 years old and who did not have decompensated cirrhosis or a hepatocellular carcinoma (HCC) at the time of inclusion were included in the study. Results: This study included 569 patients with a mean age of 32.92 years. The majority were men (58.9%) and had a high level of education (university) (78.7%). A family history of the first degree of hepatocellular carcinoma (HCC) was found in 10.5% of patients. Considering body mass index, 22.8% were overweight and 11.9% were obese. Biologically, HBeAg was negative in 84.8% of patients, and the viral load was less than 2000 IU/mL in 58.5%. Evaluation of liver fibrosis showed that 62.8% of patients had mild fibrosis (F0 - F1). The median survival time was 4.12 years. (IQC: 3:35 - 4:89). The retention rate in care was 67.47% at 01 year old, 55.68% at 03 years old, 45.51% at 05 years old, 30.61% at 10 years old, and 12.03% at 15 years. Factors significantly associated with non-retention among people living with chronic hepatitis B included male sex [adjusted HR 0.58; 95% CI: 0.35 - 0.96], secondary education level [adjusted HR 1.74; 95% CI: 1.00 - 3.02], overweight [adjusted HR 0.72; 95% CI: 0.54 - 0.97], obesity [adjusted HR 0.39; 95% CI: 0.24 - 0.64], and initiation of antiviral treatment [adjusted HR 0.36; 95% CI: 0.28 - 0.47]. Conclusion: Our study revealed low retention in care among people living with chronic hepatitis B, particularly among women and untreated patients, with a progressive decline over time. It is necessary to intensify the sensitization of in order to maintain them in care.
- Schweitzer, A., Horn, J., Mikolajczyk, R.T., Krause, G. and Ott, J.J. (2015) Estimations of Worldwide Prevalence of Chronic Hepatitis B Virus Infection: A Systematic Review of Data Published between 1965 and 2013. The Lancet , 386, 1546-1555. https://doi.org/10.1016/s0140-6736(15)61412-x
- Polaris Observatory Collaborators (2023) Global Prevalence, Cascade of Care, and Prophylaxis Coverage of Hepatitis B in 2022: A Modelling Study. The Lancet Gastroenterology and Hepatology , 8, 879, 907.
- WHO (2024) Global Hepatitis Report 2024: Action for Access in Low-and Middle-Income Countries. https://www.who.int/publications/i/item/9789240091672
- Meda, N., Tuaillon, E., Kania, D., Tiendrebeogo, A., Pisoni, A., Zida, S., et al . (2018) Hepatitis B and C Virus Seroprevalence, Burkina Faso: A Cross-Sectional Study. Bulletin of the World Health Organization , 96, 750-759. https://doi.org/10.2471/blt.18.208603
- WHO (2024) Guidelines for the Prevention, Diagnosis, Care, and Treatment of People with Chronic Hepatitis B Infection. https://www.who.int/publications/i/item/9789240090903
- European Association for the Study of the Liver, European Association for the Study of the Liver (2017) EASL 2017 Clinical Practice Guidelines on the Management of Hepatitis B Virus Infection. Journal of Hepatology , 67, 370-398.
- Terrault, N.A., Bzowej, N.H., Chang, K., Hwang, J.P., Jonas, M.M. and Murad, M.H. (2016) AASLD Guidelines for Treatment of Chronic Hepatitis B. Hepatology , 63, 261-283. https://doi.org/10.1002/hep.28156
- van Olmen, J., Schellevis, F., Van Damme, W., Kegels, G. and Rasschaert, F. (2012) Management of Chronic Diseases in Sub-Saharan Africa: Cross-Fertilisation between HIV/AIDS and Diabetes Care. Journal of Tropical Medicine , 2012, Article 349312. https://doi.org/10.1155/2012/349312
- Rachlis, B., Naanyu, V., Wachira, J., Genberg, B., Koech, B., Kamene, R., et al . (2016) Identifying Common Barriers and Facilitators to Linkage and Retention in Chronic Disease Care in Western Kenya. BMC Public Health , 16, Article No. 741. https://doi.org/10.1186/s12889-016-3462-6
- Yanogo, P.K., Sanou, E.N. and Meda, N. (2022) The Outcome of People Screened for Hepatitis B, in a Community-Based Setting in Ouagadougou, Burkina, 2018-2020. Annals of Epidemiology and Public Health , 5, Article 1074.
- Nyama, E.T., Allan‐Blitz, L., Bitwayiki, R., Swaray, M., Lebbie, W., Lavalie, D., et al . (2023) Challenges of Hepatitis B Treatment in Rural Sub-Saharan Africa: Treatment Initiation and Outcomes from a Public Hospital‐Based Clinic in Kono, Sierra Leone. Journal of Viral Hepatitis , 30, 455-462. https://doi.org/10.1111/jvh.13812